| Literature DB >> 27075204 |
Simone Riis1, Allan Stensballe2, Jeppe Emmersen1, Cristian Pablo Pennisi1, Svend Birkelund2, Vladimir Zachar1, Trine Fink3.
Abstract
BACKGROUND: Adipose-derived stem cells (ASCs) are being increasingly recognized for their potential to promote tissue regeneration and wound healing. These effects appear to be partly mediated by paracrine signaling pathways, and are enhanced during hypoxia. Mass spectrometry (MS) is a valuable tool for proteomic profiling of cultured ASCs, which may help to reveal the identity of the factors secreted by the cells under different conditions. However, serum starvation which is essentially required to obtain samples compatible with secretome analysis by MS can have a significant influence on ASCs. Here, we present a novel and optimized culturing approach based on the use of a clinically relevant serum-free formulation, which was used to assess the effects of hypoxia on the ASC proteomic profile.Entities:
Keywords: ASCs; ECM; Hypoxia; Mass spectrometry; Proteomics; Secretome; Serum-free culture
Mesh:
Substances:
Year: 2016 PMID: 27075204 PMCID: PMC4831147 DOI: 10.1186/s13287-016-0310-7
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1Preparation of samples for mass spectrometric analysis. Following the expansion of ASCs from three donors for 72 h, cells were cultured under either normoxic or hypoxic conditions for 24 h. The conditioned media were harvested and sequentially fractionated through 30-kDa and 3-kDa spin filters to retain the secretome and peptidome fractions, respectively. The cellular fraction was employed for the analysis of the proteome. ASC adipose-derived stem cell
Fig. 2Effects of culture supplements on the growth and viability of the ASCs. a Growth curves of ASCs expanded for 3 days in the different media formulations. At day 3, there was a significantly higher number of cells in the StemPro + cultures as compared to the cultures with the other two media formulations (***p < 0.001, n = 6). b Cells expanded for 3 days in StemPro + and preconditioned for 24 h in the different media. After preconditioning, the number of cells in StemPro– cultures had significantly decreased in relation to the StemPro + cultures (**p < 0.01, n = 6). The percentage of viable cells was equivalent among the different formulations. c Phase contrast microphotographs displaying the morphology of cells after the preconditioning period in different media. The figure shows representative pictures from one donor. Scale bar = 200 μm
Fig. 3Analysis of the proteome of the ASCs by mass spectrometry. a Venn diagrams showing the concurrence in identified proteins in the proteome from the three donors (ASC 12, 21 and 23) exposed to either normoxic or hypoxic preconditioning. b Principal component analysis (PCA) of the proteome fractions in all samples. Shown are PCA score plots of principle components 1 and 2 of the protein abundances as measured in the normoxic and hypoxic samples from all three donors in four biological replicates. Red, ASC 12; green, ASC 21; blue, ASC 23; square, normoxic; cross, hypoxic. c Statistical analysis of the difference between label-free samples of the proteome fraction from hypoxic preconditioned ASC 21 against the proteome fraction from normoxic preconditioned ASC21 with a two-sided t test. The results are visualized by a scatter plot (volcano plot). The –log t test p value is plotted against the t test difference log2 for each protein. The proteins significantly changed between the samples (p < 0.05) are in the right and left upper corners (red). ASC adipose-derived stem cell
Fig. 4Gene ontology (GO) analysis of genes upregulated by hypoxic preconditioning of ASCs. The analysis was performed in Cytoscape using the BiNGO plug-in version 3.0.3. Presented is a reduced network showing all biological process categories that were significantly over-represented based on the genes corresponding to the upregulated proteins identified from all three donors. The color scale indicates the level of significance of the overrepresented GO category (adjusted p < 0.05). The size of the circles is proportional to the number of genes in each category. ECM extracellular matrix
Enriched biological processes based on upregulated proteins
| Description | Genes involved |
|
|---|---|---|
| Metabolism (anaerobic) | ||
| Glycolysis | GPI, LDHA|TPI1, PGK1, ENO2, ALDOA, HK2, PFKP | 0.0000 |
| Gluconeogenesis | GPI, TPI1, ENO2 | 0.0101 |
| Fructose 1,6-bisphosphate metabolic process | ALDOA, PFKP | 0.0123 |
| Glycogen biosynthetic process | GYS1, GBE1 | 0.0285 |
| Oxidation reduction | LDHA, LOX, P4HA1, P4HA2, FTH1, CYP51A1 | 0.0245 |
| Protein folding | LRPAP1, PFDN4, HSPBP1, PFDN6, ERO1L | 0.0469 |
| ECM and tissue development | ||
| Collagen fibril organization | COL1A1, COL3A1, LOX, P4HA1 | 0.0010 |
| Peptidyl-proline hydroxylation to 4-hydroxy- | P4HA1, P4HA2 | 0.0046 |
| Collagen biosynthetic process | COL1A1, COL3A1 | 0.0123 |
| Epidermis development | COL1A1, COL3A1, CRABP2, COL7A1, TXNIP, PLOD1 | 0.0181 |
| Cell proliferation | CDV3, LRPAP1, NUMBL, CD81 | 0.0474 |
| Cell adhesion mediated by integrin | ITGA5, ICAM1 | 0.0255 |
| Response to stimulus | ||
| Response to inorganic substance | COL1A1, FNTA, BSG, TPM1, TXNIP, ACO1, NDRG1 | 0.0128 |
| Cellular response to growth factor stimulus | COL1A1, EMD | 0.0333 |
| Response to abiotic stimulus | IKBIP, COL1A1, COL3A1, FECH | 0.0333 |
| Nucleus | ||
| Nuclear envelope organization | LMNA, EMD | 0.0285 |
| Nucleocytoplasmic transport | LSG1, LMNA, TXNIP, NUTF2, AGFG1 | 0.0285 |
ECM extracellular matrix
Fig. 5Gene ontology (GO) analysis of genes downregulated by hypoxic preconditioning of ASCs. The analysis was performed in Cytoscape using the BiNGO plug-in version 3.0.3. Presented is a reduced network showing all biological process categories that were significantly over-represented based on the genes corresponding to the downregulated proteins identified from all three donors. The color scale indicates the level of significance of the over-represented GO category (adjusted p < 0.05). The size of the circles is proportional to the number of genes in each category
Enriched biological processes based on downregulated proteins
| Description | Genes involved |
|
|---|---|---|
| Metabolism (aerobic) | ||
| Tricarboxylic acid cycle | CS, FH, SUCLA2, MDH2, IDH3G, SUCLG2 | 0.0000 |
| Succinyl-CoA metabolic process | SUCLA2, SUCLG2, SUCLG1 | 0.0004 |
| mitochondrial electron transport, NADH to ubiquinone | NDUFA9, NDUFB9, NDUFA8, NDUFB8, NDUFS8, NDUFB10 | 0.0000 |
| Mitochondrial electron transport, ubiquinol to cytochrome c | UQCRC1, UQCR10 | 0.0335 |
| 2-Oxoglutarate metabolic process | IDH3G, DLD, IDH3A | 0.0253 |
| Malate metabolic process | FH, MDH2, ME2 | 0.0042 |
| Isocitrate metabolic process | IDH3G, IDH3A | 0.0335 |
| Branched chain family amino acid metabolic process | HIBADH, HIBCH, BCAT2 | 0.0298 |
| Proline biosynthetic process | PYCR1, PYCR2 | 0.0479 |
| NADH metabolic process | MDH2, IDH3G, IDH3A | 0.0060 |
| Aspartate transport | SLC25A12, SLC25A13 | 0.0479 |
| Malate-aspartate shuttle | SLC25A12, SLC25A13 | 0.0137 |
| Regulation of acetyl-CoA biosynthetic process from pyruvate | PDP1, PDHB, DLD | 0.0128 |
| Oxaloacetate metabolic process | CS, MDH2, PCK2 | 0.0106 |
| Protein targeting to mitochondrion | TOMM40, TOMM34, TIMM44, TOMM22 | 0.0198 |
| Gene expression | ||
| Nuclear mRNA splicing, via spliceosome | SF3B4, PRPF4, SF3A2, SNRPD1, DHX38 | 0.0001 |
| Translational elongation | GFM1, RPL21, RPL22, RPL13, RPL27, EEF2, TUFM | 0.0099 |
| DNA-dependent DNA replication initiation | MCM7, MCM3, MCM6 | 0.0253 |
| tRNA modification | QTRT1, SSB, NSUN2 | 0.0335 |
| Ribonucleoprotein complex assembly | SF3A2, SNRPD1, CIRBP, GEMIN5, USP39, WDR77 | 0.0147 |
| Response to stress | ||
| Detection of oxygen | SOD2, ENG | 0.0335 |
| DNA damage response, detection of DNA damage | MRPS9, PARP1, MRPS35 | 0.0017 |